Atrial Secondary Tricuspid Regurgitation
JACC: Cardiovascular Interventions · 2024-12 · 17 (23) · 2781-2791
DOI: 10.1016/j.jcin.2024.10.028 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-12. Verfasst von Lukas Stolz und 51 weiteren Autor:innen. Beteiligte Einrichtung: Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Hear…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Registries, Severity of Illness Index, Tricuspid Valve. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Atrial secondary tricuspid regurgitation (A-STR) has been proposed as an important etiologic subentity of secondary tricuspid regurgitation (STR). Patients with A-STR are frequently treated using transcatheter tricuspid valve edge-to-edge repair (T-TEER). OBJECTIVES: The aims of this study were to evaluate prevalence and outcomes following T-TEER for severe A-STR and to compare the results to patients with nonatrial STR. METHODS: The study included patients from the EuroTR (European Registry of Transcatheter Repair for Tricuspid Regurgitation) registry who underwent T-TEER for STR from 2016 until 2022. A-STR was defined as a ratio of end-systolic right atrial area to right ventricular area ≥1.5 in the presence of preserved right ventricular function (tricuspid annular plane systolic excursion >17 mm). The primary study endpoint was 2-year survival free from heart failure hospitalization. Secondary endpoints were 2-year survival, tricuspid regurgitation (TR) reduction at discharge and 1-year follow-up as well as changes in NYHA functional class. RESULTS: This study included 641 patients (50% women) with a mean age of 79 ± 7 years. The overall prevalence of A-STR was 31% (n = 196). A-STR was associated with a higher prevalence of atrial fibrillation, less frequent comorbidities, better biventricular function, less leaflet tenting, and larger atria. Although TR severity was comparable at baseline, patients with A-STR had more effective procedural TR reduction (TR ≤2+ in 86.9% vs 80.4% of those with nonatrial STR; P = 0.005). Although NYHA functional class improved in both STR subetiologies, the symptomatic burden was lower in patients with A-STR at the latest available follow-up (NYHA functional class ≥III in 46% of patients with nonatrial STR vs 38% in those with A-STR; P = 0.033). Beyond that, A-STR was associated with higher 2-year survival rates free from heart failure hospitalization (66.3% [Q1-Q3: 58.2%-75.5%] vs 47.5% [Q1-Q3: 41.7%-54.7%] in patients with nonatrial STR; P < 0.001). Median survival follow-up was 379 days [Q1-Q3: 155-697 days]. CONCLUSIONS: A-STR is a common phenotype of STR and is associated with effective TR reduction and symptomatic reduction after T-TEER.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany.
- Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Department of Cardiology, Heart Center, University of Cologne, Cologne, Germany.
- Department of General and Interventional Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
- Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center of Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Hamburg,…
- Department of Cardiology, University Heart Center Ulm, Ulm, Germany.
Zitieren
APA
Stolz, L., Kresoja, K. P., von Stein, J., Fortmeier, V., Koell, B., Rottbauer, W., Kassar, M., Goebel, B., Denti, P., Achouh, P., Rassaf, T., Barreiro-Perez, M., Boekstegers, P., Rück, A., Doldi, P. M., Novotny, J., Zdanyte, M., Adamo, M., Vincent, F., …, & EuroTR Investigators (2024). Atrial Secondary Tricuspid Regurgitation. JACC: Cardiovascular Interventions, 17(23), 2781-2791. https://doi.org/10.1016/j.jcin.2024.10.028
Vancouver
Stolz L, Kresoja KP, von Stein J, Fortmeier V, Koell B, Rottbauer W, et al. Atrial Secondary Tricuspid Regurgitation. JACC: Cardiovascular Interventions. 2024;17(23):2781-2791. doi:10.1016/j.jcin.2024.10.028
BibTeX
@article{Stolz2024,
author = {Stolz, Lukas and Kresoja, Karl-Patrik and von Stein, Jennifer and Fortmeier, Vera and Koell, Benedikt and Rottbauer, Wolfgang and Kassar, Mohammad and Goebel, Bjoern and Denti, Paolo and Achouh, Paul and Rassaf, Tienush and Barreiro-Perez, Manuel and Boekstegers, Peter and Rück, Andreas and Doldi, Philipp M and Novotny, Julia and Zdanyte, Monika and Adamo, Marianna and Vincent, Flavien and Schlegel, Philipp and von Bardeleben, Ralph Stephan and Stocker, Thomas J and Weckbach, Ludwig T and Wild, Mirjam G and Besler, Christian and Brunner, Stephanie and Toggweiler, Stefan and Grapsa, Julia and Patterson, Tiffany and Thiele, Holger and Kister, Tobias and Tarantini, Giuseppe and Masiero, Giulia and De Carlo, Marco and Sticchi, Alessandro and Konstandin, Mathias H and Van Belle, Eric and Metra, Marco and Geisler, Tobias and Estévez-Loureiro, Rodrigo and Luedike, Peter and Karam, Nicole and Maisano, Francesco and Lauten, Philipp and Praz, Fabien and Kessler, Mirjam and Kalbacher, Daniel and Rudolph, Volker and Iliadis, Christos and Lurz, Philipp and Hausleiter, Jörg and EuroTR Investigators, EuroTR Investigators},
title = {Atrial Secondary Tricuspid Regurgitation},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {23},
pages = {2781--2791},
doi = {10.1016/j.jcin.2024.10.028}
}
EUVIMED